spacer
home > ict > spring 2018 > improving success rates
PUBLICATIONS
International Clinical Trials

Improving Success Rates

Innovative methodologies are paving the way to a better outlook for Alzheimer’s clinical trials. Improvements in understanding of pathophysiological mechanisms, innovative clinical trial design, and better operational oversight are addressing well-documented research challenges associated with this complex, multifaceted disease.

Daunting failure rates – reaching 99.6% – have historically plagued advancement of new treatments and potential cures for the 28-37 million people impacted (1,2). However, new insights are helping investigators address a continuing source of problematic research: patient recruitment.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Michael F Murphy’s professional career has spanned 25 years and his positions within the pharma industry emphasise the integration of medical and scientific acumen with operational excellence. He is board-certified in psychiatry and has a doctorate in pharmacology, with training at Tulane University, Stanford University, and the Mt Sinai School of Medicine, US. Michael worked with Dr Cutler in articulating this vision for Worldwide Clinical Trials when the company was established as a global CRO in 1995. His supervisory responsibilities as Chief Medical and Scientific Officer at Worldwide are international in scope.
spacer
Dr Michael F Murphy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement